Skip to main
CANF
CANF logo

CANF Earnings Dates & Reports

CANF Most Recent Earnings

Report DateMar 28, 2024
Period EndingQ4 2023
Est. EPS-$0.26
Actual EPS-$0.01
EarningsBeat

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

CANF Earnings per Share (EPS) History

Signup for full access
Browse free

CANF Latest Earnings

The value each CANF share was expected to gain vs. the value each share gained.

CANF reported its most recent earnings on Mar 28, 2024 for Q4 2023, posting earnings per share (EPS) of -$0.01. This exceeded analysts' expectations of -$0.26 by 96.15%, marking a Beat.

For comparison, Can-Fite BioPharma Ltd. reported EPS of -$1.11 in the same quarter last year.

The company is expected to announce its next earnings report on 01/03/2025, with analysts projecting an EPS of -$1.60.

CANF Earnings History

Earnings
Est. EPSActual EPSSurprise
Q2 2024Jan 3, 2025
-$0.41Next earnings call Jan. 3, 2025
Q4 2023Mar 28, 2024
-$0.26-$0.01-96.15%
DeckReportListen
Q3 2023Nov 30, 2023
-$0.44-$0.43-2.27%
Q2 2023Aug 31, 2023
-$0.42-$0.40-4.76%
Q1 2023Jun 1, 2023
-$1.52-$0.65-57.24%
View all

CANF Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Can-Fite BioPharma Ltd.’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange
Mar 28, 2024
Nov 30, 2023
Aug 31, 2023
Jun 1, 2023

CANF Earnings FAQs

CANF last reported earnings on Mar 28, 2024 for Q4 2023, posting an EPS of -$0.01, which Beat the estimate of -$0.26 by 96.15%.

For Q4 2023, CANF reported an EPS of -$0.01, exceeding analysts' estimate of -$0.26 by 96.15%.

For Q4 2023, CANF Beat expectations with an actual EPS of -$0.01 vs. an estimated EPS of -$0.26.

Following the last earnings report on Mar 28, 2024, CANF's stock price moved — from — to —.

The next CANF earnings call is scheduled for Jan. 3, 2025, where executives will discuss financial results and outlook.

Can-Fite BioPharma Ltd. (CANF)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.